Maintenance of pulmonary rehabilitation benefits in patients with COPD: is a structured 5-year follow-up program helpful?

Maintenance of pulmonary rehabilitation benefits in patients with COPD: is a structured 5-year follow-up program helpful?

Background/aim: Pulmonary rehabilitation (PR) has proven useful in patients with chronic obstructive pulmonary disease (COPD), but the benefits decrease over time. We evaluated the effects of a structured follow-up program after PR on patient pulmonary function, dyspnea, body composition, exercise capacity, quality of life, psychological status, i-BODE index, hospitalization status, 5-year survival rate. We explored whether this follow-up program could serve as a maintenance program. Materials and methods: COPD patients who completed PR attended follow-up visits over 5 years. We administered incremental (ISWT), endurance shuttle walk tests (ESWT), measured body (BMI), fat-free mass indices (FFMI), recorded modified Medical Research Council (mMRC), St. George’s respiratory questionnaire (SGRQ), anxiety-depression scores. We also noted the forced expiratory volume in 1 s (FEV1), the forced vital capacity (FVC), the forced midexpiratory flow (FEF25-75), hospitalization, survival rates before, after PR, and in years 1, 2, 3, 5. This was a retrospective observational study. Results: Thirty-three COPD patients with a mean age of 58 ± 8 years were enrolled. Twenty-seven (82%) were male. The mean FEV1 was 47 ± 16% of the predicted. After PR, the mMRC scale, SGRQ, anxiety, depression scores; i-BODE index; ISWT, ESWT results improved (all p < 0.001), with the improvements persisting through the first year. Patient body composition, pulmonary function did not differ from the baseline over the 5 years (except for a decrease in the FEF25-75 value in year 5; p = 0.003). The hospitalization rate, i-BODE index did not change significantly over the 5 years, the improvements in the ISWT, ESWT outcomes were preserved for 3 years (p = 0.013/0.005, respectively). The quality-of-life, anxiety scores deteriorated in year 1 (both p < 0.001) and year 3 (p = 0.005/0.010, respectively). The dyspnea, depression scores increased progressively over the 5 years. Conclusion: Structured follow-up programs with visits at 6-month intervals may effectively maintain improvements in COPD. Longterm randomized controlled studies are needed to verify these results.Key words: COPD, structured pulmonary rehabilitation programs, exercise capacity, dyspnea

___

  • 1. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidencebased clinical practice guidelines. Chest 2007; 131 (5): 4–42. doi: 10.1378/chest.06-2418
  • 2. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L et al. ATS/ERS Task Force on Pulmonary Rehabilitation. An official American Thoracic Society / European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory Critical Care Medicine 2013; 188: 13– 64. doi: 10.1164/rccm.201309-1634ST
  • 3. Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL et al. British Thoracic Society Pulmonary Rehabilitation Guideline Development Group; British Thoracic Society Standards of Care Committee. British Thoracic Society guideline on pulmonary rehabilitation in adults: accredited by NICE. Thorax 2013; 68: 1–30. doi: 10.1136/thoraxjnl-2013-203808
  • 5. McCarthy B, Casey D, Devane D, Murphy K, Murphy E et al. Cochrane Airways Group. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Review 2015; 3: 37-93. doi: 10.1002/14651858.CD003793. pub3
  • 6. Beauchamp MK, Evans R, Janaudis-Ferreira T, Goldstein RS, Brooks D. Systematic review of supervised exercise programs after pulmonary rehabilitation in individuals with COPD. Chest 2013; 144: 1124–1133. doi: 10.1378/chest.12-2421
  • 7. Jenkins AR, Gowler H, Curtis F, Holden NS, Bridle C et al. Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis. International Journal of Chronic Obstructive Pulmonary Disease 2018; 13: 257–273. doi: 10.2147/COPD. S150650
  • 8. Güell MR, Cejudo P, Ortega F, Puy MC, Rodríguez-Trigo G et al. Benefits of long-term pulmonary rehabilitation maintenance program in patients with severe chronic obstructive pulmonary disease. American Journal of Respiratory Critical Care Medicine 2017; 195: 622–629. doi: 10.1164/rccm.201603-0602OC
  • 9. Blervaque, L, Préfaut, C, Forthin, H, Maffre F, Bourrelier M et al. Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study. Respiratory Research 2021; 22: 79-83. doi:10.1186/s12931-021-01674-3
  • 10. Singh SJ, Morgan MDL, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47: 1019-1024. doi: 10.1136/thx.47.12.1019
  • 11. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. European Respiratory Journal 2014; 44: 1428–1446. doi:10.1183/09031936.00150314
  • 12. Evans RA, Singh S. Minimum important difference of the incremental shuttle walk test distance in patients with COPD. Thorax 2019; 74 (10): 994-995. doi: 10.1136/ thoraxjnl-2019-214023
  • 13. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. European Respiratory Journal 2002; 19 (3): 398-404. doi: 10.1183/09031936.02.00063702
  • 14. Fletcher CM. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of Chronic Bronchitis (MRC breathlessness score). British Medical Journal 1960; 2: 16-65.
  • 15. Gibson JG, Whitelaw W, Siafakas N, Green M, Road J et al. American Thoracic Society/European Respiratory Society. ATS/ ERS Statement on respiratory muscle testing. American Journal of Respiratory Critical Care Medicine 2002; 166 (4): 518-624. doi: 10.1164/rccm.166.4.518
  • 16. Aydemir O, Güvenir T, Küey L, Kültür S. Reliability and Validity of the Turkish version of Hospital Anxiety and Depression Scale. Turkish Journal of Psychiatry 1997; 8: 280-287.
  • 17. Williams JE, Green RH, Warrington V, Steiner MC, Morgan MD et al. Development of the i-BODE: Validation of the incremental shuttle walking test within the BODE index. Respiratory Medicine 2012; 106 (3): 390–396. doi: 10.1016/j. rmed.2011.09.005
  • 18. Schols AM, Ferreira IM, Franssen FM, Gosker HR, Janssens W et al. Nutritional assessment and therapy in COPD: a European Respiratory Society statement. European Respiratory Journal 2014; 44 (6) : 1504-1520. doi: 10.1183/09031936.00070914
  • 19. Garvey C, Bayles MP, Hamm LF, Hill K, Holland A et al. Pulmonary Rehabilitation Exercise Prescription in Chronic Obstructive Pulmonary Disease: Review of Selected Guidelines: An Official Statement From The American Association Of Cardiovascular And Pulmonary Rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 2016; 36 (2): 75-83. doi: 10.1097/ HCR.0000000000000171
  • 20. Etchison WC, Curd DT. American College of Sports Medicine Position Stand. The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness. Medicine & Science in Sports & Exercise 1998; 30 (6): 975-991.
  • 21. Langer D, Hendriks E, Burtin C, Probst V, van der Schans CP et al. A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clinical Rehabilitation 2009; 23 (5): 445–462. doi: 10.1177/0269215509103507
  • 22. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease [review]. Cochrane Database Systemic Review 2011; 5 (10): 53-105. doi: 10.1002/14651858.CD005305.pub3
  • 23. Qaseem A, Snow V, Shekelle P, Sherif K, Wilt TJ et al. Clinical Efficacy Assessment Subcommittee of the American College of Physicians. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2007; 147 (9): 633–638.
  • 24. Wilt TJ, Niewoehner D, MacDonald R, Kane RL. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Annals of Internal Medicine 2007; 147 (9): 639–653. doi: 10.7326/0003-4819-147- 9-200711060-00009
  • 25. Casanova C, de Torres JP, Aguirre-Jaime A, Pinto-Plata V, Marin JM et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. American Journal of Respiratory Critical Care Medicine 2011; 184 (9): 1015–1021. doi: 10.1164/rccm.201105-0831OC
  • 26. Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A et al. Changes in forced expiratory volume in 1 second over time in COPD. The New England Journal of Medicine 2011; 365 (13): 1184–1192. doi: 10.1056/NEJMoa1105482
  • 27. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F et al. Interpretative strategies for lung function tests. European Respiratory Journal 2005; 26 (5): 948–968. doi: 10.1183/09031936.05.00035205
  • 28. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. American Journal of Respiratory Critical Care Medicine 2007; 175: 458–463. doi: 10.1164/rccm.200607-896OC
  • 29. Hundal M, Ghattas C, Price LL, Lacamera P, Unterborn J. Forced Mid-Expiratory Flow Can Predict Ventilatory Limitation and Exercise Capacity. Internal Journal of Respiratory Pulmonary Medicine 2019; 6 (1): 101-104. doi: 10.23937/2378- 3516/1410104
  • 30. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. American Journal of Respiratory Critical Care Medicine 2003; 167 (6): 880–888.
  • 31. Spencer LM, Alison JA, McKeough ZJ. Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial. European Respiratory Journal 2010; 35 (3): 571–577. doi: 10.1183/09031936.00073609
  • 32. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest. 2001; 119 (6): 1696–1704. doi: 10.1378/chest.119.6.1696
  • 33. Hill K, Bansal V, Brooks D, Goldstein RS. Repeat pulmonary rehabilitation programs confer similar increases in functional exercise capacity to initial programs. Journal of Cardiopulmonary Rehabilitation and Prevention 2008; 28 (6): 410–414. doi: 10.1097/HCR.0b013e31818c3c8d
  • 34. Emery CF, Shermer RL, Hauck ER, Hsiao ET, MacIntyre NR. Cognitive and psychological outcomes of exercise in a 1-year follow-up study of patients with chronic obstructive pulmonary disease. Health Psychology 2003; 22 (6): 598–604. doi: 10.1037/0278-6133.22.6.598
  • 35. Moore E, Palmer T, Newson R, Majeed A, Quint JK et al. Pulmonary rehabilitation as a mechanism to reduce hospitalizations for acute exacerbations of COPD: a systematic review and meta-analysis. Chest 2016; 150: 837-859. doi:10.1016/j.chest.2016.05.038
  • 36. Camillo CA, Langer D, Osadnik CR, Pancini L, Demeyer H et al. Survival after pulmonary rehabilitation in patients with COPD: impact of functional exercise capacity and its changes. Internal Journal of Chronic Obstructive Pulmonary Disease 2016; 11: 2671–2679. doi: 10.2147/COPD.S113450
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Heart rate turbulence measurements in patients with dipper and non-dipper hypertension: the effects of autonomic functions

Vahit DEMİR, Çağlar AL, Mehmet Tolga DOGRU

Giant hepatic hemangioma treatment with transcatheter arterial embolisation and transcatheter arterial chemoembolisation; Comparative results

Hakkı Timur SİNDEL, Özhan ÖZGÜR

Can thrombocytosis or thrombocytopenia predict complicated clinical course and 30-days mortality in patients with pneumonia?

Raziye Sinem MISIRLIOĞLU, Emre ŞANCI, Kemal Can TERTEMİZ, Ersin AKSAY

Calcitonin levels in washout samples vs. cytology in the detection of malignant lymph node metastasis in recurrent medullary thyroid cancer

Asena GÖKÇAY CANPOLAT, Demet ÇORAPÇIOĞLU, Mustafa ŞAHİN, Özgür DEMİR, Koray CEYHAN, Rıfat EMRAL, Murat Faik ERDOĞAN, Sevim GÜLLÜ, Serpil SAK

Biliary stents are forgotten more frequently in elderly patients

Sadettin HÜLAGÜ, Ali Erkan DUMAN, Hasan YILMAZ

Maintenance of pulmonary rehabilitation benefits in patients with COPD: is a structured 5-year follow-up program helpful?

İpek CANDEMIR, Pınar ERGÜN, Mustafa Engin ŞAHİN

Protective effects of anandamide against cisplatin-induced peripheral neuropathy in rats

Çiğdem ÇENGELLİ ÜNEL, Başak AYAZ, Kevser EROL, Emel ULUPINAR, Şule AYDIN, Bilgin KAYGISIZ, Engin YILDIRIM, Orhan ÖZATİK

Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate

Aysun AYBAL KUTLUGÜN, Esin BEYAN, Betül ERGÜN, Mustafa Çağrı ERGÜN, Galip AKTÜRK

Frequency of peripheral blood eosinophilia and obstructive airway disease in sarcoidosis

Burcu BARAN KETENCİOĞLU, Nuri TUTAR, İnci GÜLMEZ, Fatma Sema OYMAK, İnsu YILMAZ, Bilal RABAHOĞLU

The evaluation of breast findings detected through different visualisation techniques in acromegaly patients — a retrospective study

Muhammed KIZILGÜL, Erman ÇAKAL, Muhammed Erkam SENCAR, Hayri BOSTAN, Sema HEPŞEN, Pınar AKHANLI, Hakan DÜĞER, Bekir UÇAN